CD274 and neoplasm: Following treatment with CAR-T cells, tumor cells release dsDNA, which then activated AIM2 inflammatory vesicles, and induced upregulation of PD-L1 expression and 2,3-dioxygenase (IDO) on macrophages, thereby inhibiting the cytotoxicity of CAR-T cells and limiting the therapeutic effect of CAR-T.